catechin has been researched along with irinotecan in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Graber, AY; Innocenti, F; Komoroski, BJ; Mirkov, S; RamÃrez, J; Ratain, MJ; Strom, SC | 1 |
Chen, TC; Hofman, FM; Lee, AS; Pyrko, P; Schönthal, AH | 1 |
Lin, LC; Tsai, TH; Wang, MN | 1 |
Ben Lagha, A; Grenier, D; Vaillancourt, K | 1 |
Chen, D; Chen, L; Dong, J; Geng, R; Gou, H; Liu, J; Ren, S; Wu, W; Xiang, B; Yang, X; Zhang, Z | 1 |
Bharali, MK; Borah, G | 1 |
7 other study(ies) available for catechin and irinotecan
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of green tea compounds on irinotecan metabolism.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Catechin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Glucuronates; Glucuronosyltransferase; Hepatocytes; Humans; Hydroxytestosterones; Irinotecan; RNA, Messenger; Tea | 2007 |
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Caspase 7; Catechin; Cell Growth Processes; Cell Line, Tumor; Dacarbazine; Down-Regulation; Drug Screening Assays, Antitumor; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Fluorouracil; Glioblastoma; Heat-Shock Proteins; Humans; Irinotecan; Molecular Chaperones; RNA, Small Interfering; Temozolomide; Transcription Factor CHOP; Transfection | 2007 |
Food-drug interaction of (-)-epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Area Under Curve; Bile; Biological Transport; Camptothecin; Catechin; Chromatography, High Pressure Liquid; Contraindications; Dietary Supplements; Food-Drug Interactions; Glucuronides; Injections, Intravenous; Irinotecan; Male; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 2008 |
A green tea extract and epigallocatechin-3-gallate attenuate the deleterious effects of irinotecan in an oral epithelial cell model.
Topics: Catechin; Epithelial Cells; Irinotecan; Plant Extracts; Tea | 2021 |
EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells.
Topics: Antioxidants; Autophagy; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; DNA Damage; Drug Synergism; Drug Therapy, Combination; Humans; Irinotecan; Topoisomerase I Inhibitors | 2021 |
Green tea catechins in combination with irinotecan attenuates tumorigenesis and treatment-associated toxicity in an inflammation-associated colon cancer mice model.
Topics: Animals; Carcinogenesis; Catechin; Colonic Neoplasms; Humans; Inflammation; Irinotecan; Mice; Tea | 2021 |